Memorial Sloan Kettering Cancer Center Illumina, Inc. Transaction History

Memorial Sloan Kettering Cancer Center

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $127,106 - $257,600	-700 Reduced 10.16%	6,187 $1.14 Million
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $3.13 Million - $4.37 Million	-10,309 Reduced 59.95%	6,887 $2.41 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $6.97 Million - $9.03 Million	17,196 New	17,196 $6.98 Million

968

151M

2.37M

1.41M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $14.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Memorial Sloan Kettering Cancer Center, based on Form 13F filings with the SEC.

Stay updated on Memorial Sloan Kettering Cancer Center with notifications on news.